Although Wang was not able to quantify the current or near-term threat created by bacterial resistance to antibiotics, he ...

Antibiotics are overused by some and out of reach for others - fuelling resistance and leaving deadly gaps in care.

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

Company to launch Zaynich in India this fiscal; sees $7 bn market in US and EU and ₹17,000 crore in India; USFDA, EU filings ...

Global media also looks at how a rural community in Odisha is fighting forest fires with music. An investigative report ...

The company is eyeing global market worth over $7 billion. Zaynich, a new antibiotic targeting the most severe of multi-drug resistant infections, has completed its global Phase III clinical study wit ...

India carries the heaviest burden of deadly drug-resistant infections with limited antibiotic access among eight countries.

The FDA delivered a blow to Spero's hopes of bringing the carbapenem to market in a complete response letter (CRL) delivered this week, which said another trial would be required to support approval.

Am J Health Syst Pharm. 2010;67(23):2015-2024.

Carbapenem resistance represents a major concern in HAI management, as carbapenem-resistant bacteria can trigger outbreaks in hospital settings. While molecular evaluation of outbreaks typically ...

Trends in AMR-related hospitalizations over the past decade were inconsistent and varied by causative pathogen, indicating the overall burden of AMR remains substantial.

As consultant plastic surgeon at Manchester’s busy Wythenshawe Hospital, a typical day for Dr Fouzia Choukairi involves ...